Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula [Phase 3]

View source ↗

Summary

This update notes a Phase 3 trial evaluating ASC and Fibringlue for Crohn's fistula is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease with Fistula

Drugs mentioned

• ASC
• Fibringlue

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Crohn's Fistula | Phase 3 | Status: ACTIVE_NOT_RECRUITING